Literature DB >> 25028731

Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?".

Dimitrios P Kontoyiannis1, Russell E Lewis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25028731      PMCID： PMC4136037          DOI： 10.1128/AAC.03224-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  6 in total

1.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Authors:  Oliver A Cornely; Johan Maertens; Drew J Winston; John Perfect; Andrew J Ullmann; Thomas J Walsh; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow-Tee Goh; Mario Petrini; Cathy Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

2.  Echinocandin-based initial therapy in fungemic patients with cancer: a focus on recent guidelines of the infectious diseases society of america.

Authors:  Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

3.  Risk stratification for invasive aspergillosis in immunocompromised patients.

Authors:  Raoul Herbrecht; Pierre Bories; Jean-Charles Moulin; Marie-Pierre Ledoux; Valérie Letscher-Bru
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

4.  Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?

Authors:  Bernard L Marini; Anthony J Perissinotti; Angela M Huang; David G Frame; Daniel R Kaul
Journal:  Antimicrob Agents Chemother       Date:  2014-08       Impact factor: 5.191

5.  Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.

Authors:  Marisa Z R Gomes; Ying Jiang; Victor E Mulanovich; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

6.  Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.

Authors:  Marisa Z R Gomes; Victor E Mulanovich; Y Jiang; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.